Radioimmunotherapy: is avidin-biotin pretargeting the preferred choice among pretargeting methods?

Prostate-Specific Membrane Antigen (PSMA): A Potential Theranostic Biomarker in Breast Cancer.

Biomedicines·2026

Coupling Adoptive Cell Therapy with Boron Neutron Capture Therapy: Using Functional Tumor-Infiltrating Lymphocytes for Tumor Delivery of Boron Carbide Nanoparticles.

ACS nano·2025

Efficacy, toxicity, and clinical outcomes of 177Lu-PSMA-617 radioligand therapy at 5.5 GBq per cycle in patients with advanced castration-resistant prostate cancer: a prospective, single arm, phase II study.

European journal of nuclear medicine and molecular imaging·2025

Lu-PRRT Used More Intensively on Advanced Gastro-Entero-Pancreatic and Lung Neuroendocrine Neoplasms: Preliminary Results on Toxicity from a Randomized Study.

Neuroendocrinology·2024

Do we need dosimetry for the optimization of theranostics in CNS tumors?

Neuro-oncology·2024

Correlation of [68Ga]Ga-PSMA PET/CT response and PSA decline in first-line enzalutamide for metastatic castration-resistant prostate cancer patients.

European journal of nuclear medicine and molecular imaging·2024

Prognostic value and diagnostic performance of nectin-4-targeted [68Ga]Ga-FZ-NR-1 PET/CT versus [18F]FDG in recurrent or metastatic triple-negative breast cancer.

European journal of nuclear medicine and molecular imaging·2026

Practices and barriers in PET/CT use for critically ill patients: an international survey.

European journal of nuclear medicine and molecular imaging·2026

Radium-223 decreases PD-L1 expression in bone metastases: A study with [89Zr]Zr-atezolizumab PET and immunohistological correlation.

European journal of nuclear medicine and molecular imaging·2026

Baseline serum carcinoembryonic antigen (CEA) is an independent prognostic biomarker for metastatic castration-resistant prostate cancer (mCRPC) patients receiving 177Lu-PSMA therapy.

European journal of nuclear medicine and molecular imaging·2026

APOE4-dependent cholinergic/dopaminergic contributions to clinical symptoms across Alzheimer's disease spectrum: A retrospective observational study.

European journal of nuclear medicine and molecular imaging·2026

Patient selection for primary staging with [99mTc]Tc-PSMA SPECT/CT: influence of combined PSA and ISUP grade on detection of metastatic disease.

European journal of nuclear medicine and molecular imaging·2026

Necrosis or Related Skin Changes After Subcutaneous Injection of Buprenorphine Extended-Release: A Case Series.

International journal of addiction nursing·2026

Natural language processing-based model to predict radiation pneumonitis in patients with locally advanced non-small cell lung cancer undergoing chemoradiotherapy: a retrospective cohort study.

EClinicalMedicine·2026

Quality assurance for deep learning-based proton therapy planning in routine clinical use for oropharyngeal cancer.

Physics and imaging in radiation oncology·2026

Self-rolling film for in vivo drug delivery to limit colonic inflammation induced after radiation exposure.

iScience·2026

Predicting the benefit of adaptive radiotherapy in head and neck Cancer using cone-beam computed tomography.

Physics and imaging in radiation oncology·2026

Sunitinib-Induced Hand-Foot Skin Reaction: A Case Report.

Cureus·2026

Related Experiment Videos

Radioimmunotherapy: is avidin-biotin pretargeting the preferred choice among pretargeting methods?

Related Concept Videos

Prostate-Specific Membrane Antigen (PSMA): A Potential Theranostic Biomarker in Breast Cancer.

Coupling Adoptive Cell Therapy with Boron Neutron Capture Therapy: Using Functional Tumor-Infiltrating Lymphocytes for Tumor Delivery of Boron Carbide Nanoparticles.

Efficacy, toxicity, and clinical outcomes of 177Lu-PSMA-617 radioligand therapy at 5.5 GBq per cycle in patients with advanced castration-resistant prostate cancer: a prospective, single arm, phase II study.

Lu-PRRT Used More Intensively on Advanced Gastro-Entero-Pancreatic and Lung Neuroendocrine Neoplasms: Preliminary Results on Toxicity from a Randomized Study.

Do we need dosimetry for the optimization of theranostics in CNS tumors?

Correlation of [68Ga]Ga-PSMA PET/CT response and PSA decline in first-line enzalutamide for metastatic castration-resistant prostate cancer patients.

Prognostic value and diagnostic performance of nectin-4-targeted [68Ga]Ga-FZ-NR-1 PET/CT versus [18F]FDG in recurrent or metastatic triple-negative breast cancer.

Practices and barriers in PET/CT use for critically ill patients: an international survey.

Radium-223 decreases PD-L1 expression in bone metastases: A study with [89Zr]Zr-atezolizumab PET and immunohistological correlation.

Baseline serum carcinoembryonic antigen (CEA) is an independent prognostic biomarker for metastatic castration-resistant prostate cancer (mCRPC) patients receiving 177Lu-PSMA therapy.

APOE4-dependent cholinergic/dopaminergic contributions to clinical symptoms across Alzheimer's disease spectrum: A retrospective observational study.

Patient selection for primary staging with [99mTc]Tc-PSMA SPECT/CT: influence of combined PSA and ISUP grade on detection of metastatic disease.

Necrosis or Related Skin Changes After Subcutaneous Injection of Buprenorphine Extended-Release: A Case Series.

Natural language processing-based model to predict radiation pneumonitis in patients with locally advanced non-small cell lung cancer undergoing chemoradiotherapy: a retrospective cohort study.

Quality assurance for deep learning-based proton therapy planning in routine clinical use for oropharyngeal cancer.

Self-rolling film for in vivo drug delivery to limit colonic inflammation induced after radiation exposure.

Predicting the benefit of adaptive radiotherapy in head and neck Cancer using cone-beam computed tomography.

Sunitinib-Induced Hand-Foot Skin Reaction: A Case Report.

Related Experiment Videos

Radioimmunotherapy: is avidin-biotin pretargeting the preferred choice among pretargeting methods?

Related Concept Videos

Related Articles